[Journal logo]

Volume 67 
Part 5 
Pages o1160-o1161  
May 2011  

Received 11 April 2011
Accepted 11 April 2011
Online 16 April 2011

Key indicators
Single-crystal X-ray study
T = 100 K
Mean [sigma](C-C) = 0.005 Å
Disorder in main residue
R = 0.052
wR = 0.141
Data-to-parameter ratio = 9.1
Details
Open access

17-Deoxoestrone [estra-1,3,5(10)-trien-3-ol]-methanol (3/1)

aDepartment of Chemistry, University of Malaya, 50603 Kuala Lumpur, Malaysia
Correspondence e-mail: edward.tiekink@gmail.com

Three independent molecules of the title estrone derivative and a molecule of methanol comprise the asymmetric unit of the title compound [systematic name: 13-methyl-6,7,8,9,11,12,13,14,15,16-decahydrocyclopenta[a]phenanthren-3-ol-methanol (3/1)], 3C18H24O·CH3OH. Two of the estrone molecules exhibit 50:50 disorder (one displays whole-molecule disorder and the other partial disorder in the fused five- and six-membered rings) so that five (partial) molecular conformations are discernable. The conformation of the six-membered ring abutting the aromatic ring is close to a half-chair in all five components. The conformation of the six-membered ring fused to the five-membered ring is based on a chair with varying degrees of distortion ranging from minor to significant. Two distinct conformations are found for the five-membered ring: in four molecules, the five-membered ring is twisted about the bond linking it to the six-membered ring, and in the other, the five-membered ring is an envelope with the quaternary C atom being the flap atom. The crystal packing features O-H...O hydrogen bonding whereby the four molecules comprising the asymmetric unit are linked into a supramolecular chain along the b axis.

Related literature

For the original synthesis, see: Huang-Minlon (1949[Huang-Minlon (1949). J. Am. Chem. Soc. 71, 3301-3303.]). For geometric and structural features for a series of cholestane derivatives, see: Rajnikant et al. (2006[Rajnikant, Dinesh, & Bhavnaish, C. (2006). Acta Cryst. A62, 136-145.]). For background to steroidal estrogen boronic acids and boronates, see: Ketuly & Hadi (2010[Ketuly, K. A. & Hadi, A. H. (2010). Molecules, 15, 2347-2356.]). For related structures see: Ketuly et al. (1997[Ketuly, K. A., Yufit, D. S., Brooks, C. J. W. & Freer, A. A. (1997). Acta Cryst. C53, 981-982.], 2010[Ketuly, K. A., Hadi, A. H. A., Ng, S. W. & Tiekink, E. R. T. (2010). Acta Cryst. E66, o2265.]).

[Scheme 1]

Experimental

Crystal data
  • 3C18H24O·CH4O

  • Mr = 801.16

  • Monoclinic, C 2

  • a = 24.3084 (16) Å

  • b = 7.7235 (5) Å

  • c = 26.6479 (18) Å

  • [beta] = 114.292 (1)°

  • V = 4560.1 (5) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 0.07 mm-1

  • T = 100 K

  • 0.35 × 0.20 × 0.10 mm

Data collection
  • Bruker SMART APEX CCD diffractometer

  • Absorption correction: multi-scan (SADABS; Sheldrick, 1996[Sheldrick, G. M. (1996). SADABS. University of Göttingen, Germany.]) Tmin = 0.976, Tmax = 0.993

  • 21707 measured reflections

  • 5612 independent reflections

  • 4481 reflections with I > 2[sigma](I)

  • Rint = 0.050

Refinement
  • R[F2 > 2[sigma](F2)] = 0.052

  • wR(F2) = 0.141

  • S = 1.02

  • 5612 reflections

  • 616 parameters

  • 234 restraints

  • H-atom parameters constrained

  • [Delta][rho]max = 0.37 e Å-3

  • [Delta][rho]min = -0.33 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
O1-H1...O3 0.84 1.83 2.662 (3) 170
O2-H2...O4 0.84 1.82 2.655 (4) 170
O3-H3...O2 0.84 1.88 2.711 (3) 173
O4-H4...O1i 0.84 1.90 2.736 (4) 178
Symmetry code: (i) x, y-1, z.

Data collection: APEX2 (Bruker, 2009[Bruker (2009). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT (Bruker, 2009[Bruker (2009). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: ORTEP-3 (Farrugia, 1997[Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.]), DIAMOND (Brandenburg, 2006[Brandenburg, K. (2006). DIAMOND. Crystal Impact GbR, Bonn, Germany.]) and QMOL (Gans & Shalloway, 2001[Gans, J. & Shalloway, D. (2001). J. Mol. Graph. Model. 19, 557-559.]); software used to prepare material for publication: publCIF (Westrip, 2010[Westrip, S. P. (2010). J. Appl. Cryst. 43, 920-925.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: HB5844 ).


Acknowledgements

The authors thank the University of Malaya for support and greatly appreciate UMRG grant No. RG035/10BIO.

References

Brandenburg, K. (2006). DIAMOND. Crystal Impact GbR, Bonn, Germany.
Bruker (2009). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.  [CrossRef] [details]
Gans, J. & Shalloway, D. (2001). J. Mol. Graph. Model. 19, 557-559.  [CrossRef] [PubMed] [ChemPort]
Huang-Minlon (1949). J. Am. Chem. Soc. 71, 3301-3303.
Ketuly, K. A. & Hadi, A. H. (2010). Molecules, 15, 2347-2356.  [ChemPort] [PubMed]
Ketuly, K. A., Hadi, A. H. A., Ng, S. W. & Tiekink, E. R. T. (2010). Acta Cryst. E66, o2265.  [CrossRef] [details]
Ketuly, K. A., Yufit, D. S., Brooks, C. J. W. & Freer, A. A. (1997). Acta Cryst. C53, 981-982.  [CrossRef] [details]
Rajnikant, Dinesh, & Bhavnaish, C. (2006). Acta Cryst. A62, 136-145.
Sheldrick, G. M. (1996). SADABS. University of Göttingen, Germany.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Westrip, S. P. (2010). J. Appl. Cryst. 43, 920-925.  [ISI] [CrossRef] [ChemPort] [details]


Acta Cryst (2011). E67, o1160-o1161   [ doi:10.1107/S1600536811013651 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.